Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Stoddard

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Medicina|December 7, 2021
STAT3 gain-of-function mutation in an adult patientAna Laura López, Julie Niemela, Jennifer Stoddard, et al.
Health Services Research|May 18, 2006
Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United StatesLesley H Curtis, Jennifer Stoddard, Jasmina I Radeva, et al.
Journal of Clinical Immunology|October 30, 2014
Gain of Function Mutations of PIK3CD as a Cause of Primary Sclerosing CholangitisHeather N Hartman, Julie Niemela, Mary K Hintermeyer, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2024
IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypesNatchanun Klangkalya, Jennifer Stoddard, Julie Niemela, et al.
Clinical Case Reports|April 16, 2025
Role of Comprehensive Renal Genetic Testing in Diagnosing a <i>RMND-1</i> Mitochondrial Disease in Two Adult Cases Exhibiting Variable Disease PhenotypesQuinn Stein, Ryan Mascarenhas, Sumit Punj, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 19, 2019
Skewed Lymphocyte Subpopulations and Associated Phenotypes in Patients with MastocytosisJoseph M Kulinski, Robin Eisch, Michael L Young, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2020
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa InfectionFanny Legrand, Jesica Herrick, Michelle Makiya, et al.
Journal of Clinical Immunology|November 18, 2021
CARD9 Expression Pattern, Gene Dosage, and Immunodeficiency Phenotype RevisitedShubham Goel, Hye Sun Kuehn, Javier Chinen, et al.
Frontiers in Immunology|December 20, 2023
Mulibrey nanism and immunological complications: a comprehensive case report and literature reviewAndrea Gazzin, Francesca Pala, Marita Bosticardo, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2007
KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entitiesIrina Maric, Jamie Robyn, Dean D Metcalfe, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Medicina|December 7, 2021
STAT3 gain-of-function mutation in an adult patientAna Laura López, Julie Niemela, Jennifer Stoddard, et al.
Health Services Research|May 18, 2006
Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United StatesLesley H Curtis, Jennifer Stoddard, Jasmina I Radeva, et al.
Journal of Clinical Immunology|October 30, 2014
Gain of Function Mutations of PIK3CD as a Cause of Primary Sclerosing CholangitisHeather N Hartman, Julie Niemela, Mary K Hintermeyer, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2024
IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypesNatchanun Klangkalya, Jennifer Stoddard, Julie Niemela, et al.
Clinical Case Reports|April 16, 2025
Role of Comprehensive Renal Genetic Testing in Diagnosing a <i>RMND-1</i> Mitochondrial Disease in Two Adult Cases Exhibiting Variable Disease PhenotypesQuinn Stein, Ryan Mascarenhas, Sumit Punj, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 19, 2019
Skewed Lymphocyte Subpopulations and Associated Phenotypes in Patients with MastocytosisJoseph M Kulinski, Robin Eisch, Michael L Young, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2020
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa InfectionFanny Legrand, Jesica Herrick, Michelle Makiya, et al.
Journal of Clinical Immunology|November 18, 2021
CARD9 Expression Pattern, Gene Dosage, and Immunodeficiency Phenotype RevisitedShubham Goel, Hye Sun Kuehn, Javier Chinen, et al.
Frontiers in Immunology|December 20, 2023
Mulibrey nanism and immunological complications: a comprehensive case report and literature reviewAndrea Gazzin, Francesca Pala, Marita Bosticardo, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2007
KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entitiesIrina Maric, Jamie Robyn, Dean D Metcalfe, et al.
Pageof 4